Peptide Therapy Cost Breakdown 2026: What You Will Actually Pay

Peptide therapy cost varies by an order of magnitude depending on the compound, source, and delivery model. A month of sermorelin through a compounding pharmacy might cost $60. A month of branded tirzepatide at list price exceeds $1,100. The same clinical outcome — for example, growth hormone optimization — can be achieved through multiple protocols at wildly different price points.

Three factors drive pricing: the compound itself (manufacturing complexity and patent status), the distribution channel (branded pharmacy vs compounding pharmacy vs telehealth vs clinic), and insurance coverage (rare for off-label and compounded use).

This breakdown focuses on legitimate, legal pricing channels: FDA-approved drugs through retail pharmacies, compounded peptides through licensed 503A pharmacies, and telehealth-bundled protocols. Research-chemical pricing exists but is not a legal path for human use and is not included.

GLP-1 pricing in 2026 has been disrupted by the Novo Nordisk 70% price cut on oral semaglutide and increasing telehealth competition. Current typical monthly cash-pay pricing: branded Wegovy or Ozempic runs $900-$1,100 at retail pharmacies. Branded Zepbound or Mounjaro is similar at $1,050-$1,200. Oral Rybelsus (post-cut) is now $300-$450. Novo Nordisk's direct-to-patient programs offer semaglutide at $200-$500/month for cash-pay qualified patients.

Compounded semaglutide, where still legally available (some states have restricted after FDA removed it from the shortage list), runs $150-$350/month through telehealth platforms. Compounded tirzepatide runs $250-$500/month. Quality varies significantly between compounding pharmacies.

Liraglutide (Saxenda) is mostly phased out at this point given higher efficacy of weekly options, but remains available at $800-$1,000/month branded or is now available in generic form at $150-$300. For most patients, generic liraglutide is the cheapest FDA-approved weight loss peptide option in 2026, though clinical results lag the weekly alternatives.

BPC-157 and related healing peptides returned to legal compounding in 2026 after the RFK reclassification. Pricing has stabilized quickly. BPC-157 through a licensed compounding pharmacy typically runs $80-$150/month for a standard injectable protocol (250-500 mcg daily). Some clinics bundle BPC-157 with TB-500 alternatives in protocols costing $200-$350/month.

TB-500 (thymosin beta-4) remains on Category 2 and is not legally compoundable. Patients seeking the TB-500 mechanism typically use higher-dose BPC-157, alternative regenerative protocols, or research-chemical sources (not recommended for quality and legal reasons).

GHK-Cu pricing varies widely by form. Topical cosmetic preparations with low GHK-Cu concentrations run $30-$80/month and are widely available. Injectable GHK-Cu through compounding pharmacies for regenerative protocols typically runs $100-$180/month. Clinic-administered IV or subcutaneous protocols can reach $300-$500/month when bundled with other agents.

The growth hormone secretagogue category has the widest pricing range and the most cost-effective options. Sermorelin remains one of the cheapest legal peptides at $40-$90/month through compounding pharmacies. Some telehealth programs offer sermorelin at $30-$60/month as part of subscription bundles.

CJC-1295 and ipamorelin, returned to Category 1 in 2026, now run $80-$180/month as a combined stack through licensed compounding pharmacies. Branded CJC-1295/ipamorelin protocols through dedicated clinics can reach $300-$450/month when they include physician visits, lab work, and ongoing management.

MK-677 (ibutamoren, technically not a peptide but commonly used in this category) remains in a regulatory gray zone and is not typically available through legitimate US pharmacies. Research-chemical pricing exists but falls outside this legitimate-channel breakdown.

Tesamorelin (Egrifta) remains the expensive outlier in this category. As an FDA-approved drug for HIV-associated lipodystrophy, it runs $3,000-$4,500/month at retail pharmacies. Off-label use for general visceral fat reduction is rarely insurance-covered, making it a premium-tier option despite being FDA-approved.

Selank and semax, both returned to Category 1 in 2026, now price around $60-$120/month each through compounding pharmacies. Nasal spray formulations are slightly less expensive than injectable; combined protocols for comprehensive cognitive support run $120-$200/month.

Thymosin alpha-1 pricing reflects its immune-modulation positioning: $150-$280/month through compounding pharmacies for a standard protocol. It is one of the pricier Category 1 peptides given complex synthesis and storage requirements.

PT-141 (bremelanotide) is available in two forms. FDA-approved Vyleesi for female HSDD runs $300-$400 per autoinjector (one-time dose). Compounded injectable PT-141 for both male and female use (off-label) runs $150-$250/month at typical use frequencies.

Epithalon and mitochondrial peptides (MOTS-c) typically price $120-$220/month when legitimately sourced. These have returned to Category 1 compounding legal status but availability varies by pharmacy.

Peptide pricing comparisons often ignore significant ancillary costs that meaningfully change the total.

Initial physician consultation: $150-$450 for a one-time visit at most integrative clinics; $75-$150 through telehealth platforms. Some telehealth GLP-1 programs bundle this into the first-month fee.

Baseline lab work: $150-$400 depending on how comprehensive the panel is. For GLP-1 use, a reasonable baseline includes HbA1c, lipid panel, comprehensive metabolic panel, and thyroid function. For GH secretagogues, add IGF-1, cortisol, and sex hormone testing. Labs are repeated every 3-6 months typically.

Follow-up visits: $100-$250 at clinics; often included in telehealth subscriptions. Most legitimate providers require a follow-up within 30-90 days of starting.

Delivery and supplies: Syringes, alcohol swabs, sharps containers — $15-$30/month if not included with the peptide. Some pharmacies include these; many do not. Cold storage shipping for peptide vials is usually included but adds to the underlying pharmacy cost.

For a first year of peptide therapy, expect total annual cost to include 12 months of peptide cost, 1 initial consult, 3-4 follow-up visits, and 2-3 lab panels. A "$100/month peptide" becomes roughly $2,000-$2,800 all-in for year one.

The three dominant payment models deliver different cost structures. Retail pharmacy (for FDA-approved drugs) is typically the most expensive per-month but offers the highest quality control and often works with insurance when coverage applies. Best for branded GLP-1s with insurance coverage or manufacturer savings programs.

Telehealth platforms (Ro, Hims, Noom, WeightWatchers Clinic, and peptide-specific telehealth like Henry Meds, Invigor Medical, and MOTF Peptides) bundle consultation, prescription, and compounded peptide into a subscription. Monthly pricing for telehealth weight-loss programs runs $150-$400/month all-in. Best for patients who want simplicity and don't need in-person care.

Integrative/longevity clinics (Cenegenics, Human Longevity, independent anti-aging clinics) offer comprehensive peptide protocols with detailed lab work and in-person care. Pricing is the highest — $400-$1,200/month for bundled protocols — but includes hands-on physician management. Best for complex multi-peptide protocols and patients wanting more comprehensive evaluation.

For most patients pursuing straightforward peptide protocols, telehealth delivers the best cost-to-care ratio in 2026. Clinic-based care is warranted for complex presentations or multi-compound protocols.

The most cost-effective legitimate peptide protocols in 2026: sermorelin alone at $40-$90/month for GH-axis support. Generic liraglutide at $150-$300/month for weight loss where the weekly options are cost-prohibitive. BPC-157 at $80-$150/month for injury recovery. Selank or semax at $60-$120/month for cognitive use.

Conversely, the most expensive legitimate categories: branded GLP-1s without insurance at $900-$1,200/month. Tesamorelin off-label at $3,000+/month. Multi-peptide clinic protocols at $800-$1,500/month all-in.

For patients making cost-efficacy tradeoffs: semaglutide delivers ~15% weight loss at $300-$500/month compounded or $600-$900/month with savings programs. Tirzepatide delivers ~22% weight loss at $400-$600/month compounded or $700-$1,100/month branded. The marginal cost per additional percentage point of weight loss is roughly $40-$80, which most patients consider reasonable.

The worst value in peptide therapy is typically unregulated research-chemical sourcing — low upfront cost, but no quality verification, no prescribing physician relationship, and no legal protection. The $50 saved per month versus a legitimate compounding pharmacy is not worth the risk profile.